Percutaneous Mechanical Circulatory Support Devices Market Report Examines Leading Companies And Growth Opportunities

The market for percutaneous mechanical circulatory support devices is poised for significant expansion in the coming years as advancements in cardiac care continue to evolve. This segment of medical technology is gaining traction due to innovations that improve patient outcomes during complex cardiac procedures. Let's explore the projected market value, key drivers, major players, emerging trends, and segmentation of this dynamic industry.

Forecasted Market Value and Growth Dynamics of Percutaneous Mechanical Circulatory Support Devices
The percutaneous mechanical circulatory support devices market is projected to reach a valuation of $3.87 billion by 2030, growing at a robust compound annual growth rate (CAGR) of 9.4%. This upward trajectory is driven by several factors, including the integration of AI-assisted cardiac monitoring, an increase in intricate cardiac interventions, expanded usage of catheterization lab procedures, a rising demand for temporary heart support, and advancements in pump technology. Noteworthy trends shaping the market during the forecast period include minimally invasive cardiac support systems, short-term hemodynamic assistance solutions, devices designed for high-risk PCI (percutaneous coronary intervention), fast-deployment cardiac systems, and innovations focused on enhancing patient safety.

Download a free sample of the Percutaneous Mechanical Circulatory Support Devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Key Drivers Influencing Growth in the Percutaneous Mechanical Circulatory Support Devices Market
One primary factor fueling market growth is the expanding adoption of AI-assisted cardiac monitoring. This technology enables more precise real-time assessments and improves the management of cardiac patients, especially during complex interventions. As cardiac procedures become more sophisticated, the need for reliable temporary circulatory support devices rises accordingly.

Additionally, the demand for advanced pump technologies that offer enhanced performance with minimal invasiveness is propelling the market forward. These innovations cater to the growing population of patients requiring temporary heart support during surgeries or critical care scenarios, further intensifying market expansion.

View the full Percutaneous Mechanical Circulatory Support Devices market report:
https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Leading Companies Dominating the Percutaneous Mechanical Circulatory Support Devices Market
Several prominent organizations are key players in this specialized market, including Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., and Pulsatile Technologies Inc.

A notable development occurred in April 2023 when US-based Abbott Laboratories acquired Cardiovascular Systems, Inc. (CSI) for approximately US$890 million. This strategic move aims to bolster Abbott's vascular portfolio by incorporating CSI's cutting-edge orbital atherectomy systems, which treat complex peripheral and coronary artery disease. Moreover, Abbott gains access to an early-stage pipeline of complementary vascular intervention technologies, including catheter-based solutions for percutaneous mechanical circulatory support in high-risk coronary procedures. Cardiovascular Systems, Inc. specializes in developing and commercializing innovative atherectomy systems and related interventional technologies targeting peripheral and coronary artery disease.

Emerging Trends Driving Innovation in the Global Percutaneous Mechanical Circulatory Support Devices Market
Industry leaders are focusing on the development of next-generation, technologically advanced devices such as intra-aortic axial-flow pumps to improve patient outcomes while minimizing surgical risks. These devices work by supporting heart function through boosting blood flow from the left ventricle to the aorta, thus assisting circulation during critical procedures.

For example, in February 2023, Procyrion, Inc., a US medical device firm, announced the first successful human use of its Aortix pump. This innovative device is designed to prevent acute kidney injury (AKI) during cardiac surgery by enhancing renal perfusion and reducing cardiac workload. Delivered via catheter into the descending thoracic aorta, the Aortix pump supports both renal and systemic circulation, offering particular benefits for patients with compromised left ventricular function and renal issues. It can deliver flow rates up to 5.0 liters per minute and is intended for temporary use during procedures such as percutaneous coronary interventions (PCI).

Market Segmentation Reveals Dominant Categories in Percutaneous Mechanical Circulatory Support Devices
The market for percutaneous mechanical circulatory support devices is segmented by product type, application, and end-user. Key product categories include intra-aortic balloon pumps, Impella devices, extracorporeal membrane oxygenation (ECMO) systems, TandemHeart devices, and other types like centrifugal pumps and pneumatic assist devices.

Application segments cover cardiogenic shock, acute myocardial infarction, heart failure, and other conditions. In terms of end-users, hospitals, ambulatory surgical centers, and other healthcare providers form the primary customer base.

Further subcategories break down intra-aortic balloon pumps into standard and enhanced devices; Impella devices into Impella 2.5, Impella 5.0, and Impella CP (Cardiac Power); ECMO into veno-venous and veno-arterial types; TandemHeart into PUMP and PRO systems; and other types including centrifugal pumps and pneumatic assist devices.

This detailed segmentation offers a comprehensive understanding of the market landscape, highlighting areas of dominance and emerging opportunities within the percutaneous mechanical circulatory support devices industry.

Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.